The Full Wiki

More info on CD25

CD25: Wikis


Note: Many of our articles have direct quotes from sources you can cite, within the Wikipedia article! This article doesn't yet, but we're working on it! See more info or our list of citable articles.


From Wikipedia, the free encyclopedia

CD25 is the alpha chain of the IL-2 receptor[1]. It is a type I transmembrane protein present on activated T cells, activated B cells, some thymocytes, myeloid precursors, and oligodendrocytes that associates with CD122 to form a heterodimer that can act as a high-affinity receptor for IL-2.

CD25 expressed in most B-cell neoplasms, some acute nonlymphocytic leukemias, neuroblastomas, and tumor infiltrating lymphocytes. Its soluble form, called sIL-2R may be elevated in these diseases and is occasionally used to track disease progression.

Grauer et al. demonstrated a time-dependent accumulation of CD4+FoxP3+ Tregs in brain tumors with a syngeneic murine glioma GL261 model. They observed that the expression of CD25, CTLA-4, GITR, and CXCR4 on intratumoral CD4+FoxP3+ Treg during tumor growth is upregulated in a time-dependent manner. They also demonstrate that treatment with anti-CD25 MAbs significantly provokes a CD4 and CD8 T-cell-dependent destruction of glioma cells. Moreover, combining Treg depletion with administration of blocking CTLA-4 mAbs further boosted glioma-specific CD4+ and CD8+ effector T cells, as well as antiglioma IgG2a antibody titers, resulting in complete tumor eradication. This study illustrated that intratumoral accumulation and activation of CD4+FoxP3+ Tregs act as a dominant immune-escape mechanism for gliomas and underline the importance of controlling tumor-infiltrating Tregs in glioma immunotherapy.


  1. ^ Brooks MMG 451 lecture Michigan State University

External links


Got something to say? Make a comment.
Your name
Your email address